Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1981 May;134(5):405–413.

Fibrositis: Misnomer for a Common Rheumatic Disorder

Robert M Bennett 1
PMCID: PMC1272765  PMID: 6167073

Abstract

Fibrositis is a misnomer for a very common form of nonarticular rheumatism. The name implies an inflammatory process in fibroconnective tissue which has never been verified. The symptoms of fibrositis are ill-defined musculoskeletal pain made worse by stress, cold, noise and unaccustomed exercise; there is usually a significant element of depression, nonrestorative sleep, chronic fatigue and early morning stiffness. Results of physical examination are strikingly normal, apart from painful tender spots which are remarkably consistent in location from patient to patient. It is important to realize that fibrositis can complicate diseases such as rheumatoid arthritis and systemic lupus erythematosus, where its prompt recognition is essential in averting inappropriate medication. Drug therapy alone is seldom effective in alleviating symptoms; a carefully planned education program is necessary to readjust both psyche and soma.

Full text

PDF
406

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awad E. A. Interstitial myofibrositis: hypothesis of the mechanism. Arch Phys Med Rehabil. 1973 Oct;54(10):449–453. [PubMed] [Google Scholar]
  2. BRENDSTRUP P., JESPERSEN K., ASBOE-HANSEN Morphological and chemical connective tissue changes in fibrositic muscles. Ann Rheum Dis. 1957 Dec;16(4):438–440. doi: 10.1136/ard.16.4.438. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Besson J. M., Guilbaud G., Le Bars D. Descending inhibitory influences exerted by the brain stem upon the activities of dorsal horn lamina V cells induced by intra-arterial injection of bradykinin into the limbs. J Physiol. 1975 Jul;248(3):725–739. doi: 10.1113/jphysiol.1975.sp010997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Chase T. N., Murphy D. L. Serotonin and central nervous system function. Annu Rev Pharmacol. 1973;13:181–197. doi: 10.1146/annurev.pa.13.040173.001145. [DOI] [PubMed] [Google Scholar]
  5. Collins D. H. Infection and Fibrositis. Ann Rheum Dis. 1940 Dec;2(2):114–126. doi: 10.1136/ard.2.2.114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FORESTIER J., ROTES-QUEROL J. Senile ankylosing hyperostosis of the spine. Ann Rheum Dis. 1950 Dec;9(4):321–330. doi: 10.1136/ard.9.4.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Golding D. N. Hypothyroidism presenting with musculoskeletal symptoms. Ann Rheum Dis. 1970 Jan;29(1):10–14. doi: 10.1136/ard.29.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Griffin S. J., Trinder J. Physical fitness, exercise, and human sleep. Psychophysiology. 1978 Sep;15(5):447–450. doi: 10.1111/j.1469-8986.1978.tb01413.x. [DOI] [PubMed] [Google Scholar]
  9. Kelly M. The Nature of Fibrositis: II. A Study of the Causation of the Myalgic Lesion. Ann Rheum Dis. 1946 Mar;5(3):69–77. [PMC free article] [PubMed] [Google Scholar]
  10. Kraft G. H., Johnson E. W., LaBan M. M. The fibrositis syndrome. Arch Phys Med Rehabil. 1968 Mar;49(3):155–162. [PubMed] [Google Scholar]
  11. Liebeskind J. C., Paul L. A. Psychological and physiological mechanisms of pain. Annu Rev Psychol. 1977;28:41–60. doi: 10.1146/annurev.ps.28.020177.000353. [DOI] [PubMed] [Google Scholar]
  12. Marx J. L. Brain peptides: is substance P a transmitter of pain signals? Science. 1979 Aug 31;205(4409):886–889. doi: 10.1126/science.38502. [DOI] [PubMed] [Google Scholar]
  13. Mayer D. J., Price D. D., Rafii A. Antagonism of acupuncture analgesia in man by the narcotic antagonist naloxone. Brain Res. 1977 Feb;121(2):368–372. doi: 10.1016/0006-8993(77)90161-5. [DOI] [PubMed] [Google Scholar]
  14. Melzack R., Wall P. D. Pain mechanisms: a new theory. Science. 1965 Nov 19;150(3699):971–979. doi: 10.1126/science.150.3699.971. [DOI] [PubMed] [Google Scholar]
  15. Moldofsky H., Scarisbrick P., England R., Smythe H. Musculosketal symptoms and non-REM sleep disturbance in patients with "fibrositis syndrome" and healthy subjects. Psychosom Med. 1975 Jul-Aug;37(4):341–351. doi: 10.1097/00006842-197507000-00008. [DOI] [PubMed] [Google Scholar]
  16. Moldofsky H., Scarisbrick P. Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med. 1976 Jan-Feb;38(1):35–44. doi: 10.1097/00006842-197601000-00006. [DOI] [PubMed] [Google Scholar]
  17. Moldofsky H., Warsh J. J. Plasma tryptophan and musculoskeletal pain in non-articular rheumatism ("fibrositis syndrome"). Pain. 1978 Jun;5(1):65–71. doi: 10.1016/0304-3959(78)90025-8. [DOI] [PubMed] [Google Scholar]
  18. ROTSTEIN J., GOOD R. A. Steroid pseudorheumatism. AMA Arch Intern Med. 1957 Apr;99(4):545–555. doi: 10.1001/archinte.1957.00260040045005. [DOI] [PubMed] [Google Scholar]
  19. Resnick D., Niwayama G. Radiographic and pathologic features of spinal involvement in diffuse idiopathic skeletal hyperostosis (DISH). Radiology. 1976 Jun;119(3):559–568. doi: 10.1148/119.3.559. [DOI] [PubMed] [Google Scholar]
  20. Ryan L. M., Kozin F., McCarty D. J. Quantification of human plasma inorganic pyrophosphate. I. Normal values in osteoarthritis and calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum. 1979 Aug;22(8):886–891. doi: 10.1002/art.1780220812. [DOI] [PubMed] [Google Scholar]
  21. Simons D. G. Muscle pain syndromes--Part I. Am J Phys Med. 1975 Dec;54(6):289–311. [PubMed] [Google Scholar]
  22. Smythe H. A., Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis. 1977;28(1):928–931. [PubMed] [Google Scholar]
  23. Terenius L. Endogenous peptides and analgesia. Annu Rev Pharmacol Toxicol. 1978;18:189–204. doi: 10.1146/annurev.pa.18.040178.001201. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES